원료 사전 탐색/lecithin/LECITHIN
Tier 1 Monograph · SSOT 15 FieldsRaw .md (GEO) ↗
식물성 (Botanical)

LECITHIN

식약처 한글 표준명: 레시틴
대전방지제피부컨디셔닝제에모리엔트유화제
[식약처 공정서 기원 및 정의] 이 원료는 스테아릭애씨드, 팔미틱애씨드 및 올레익애씨드의 천연에 존재하는 다이글리세라이드 혼합물로 포스포릭애씨드의 콜린에스터에 결합되어 있으며 살아있는 동식물에서 발견된다.
[EU CosIng Official Definition] Lecithins. The complex combination of diglycerides of fatty acids linked to the choline ester of phosphoric acid
결론 선행 Executive Regulatory & Safety Fact BoxAEO / GEO CITATION ANCHOR

화장품에서 레시틴 (LECITHIN)의 글로벌 배합 한도와 핵심 효능·처방 기준은 무엇인가요?

레시틴(표준 INCI: LECITHIN, CAS 번호: 8002-43-5)은 화장품 처방에서 주로 대전방지제, 피부컨디셔닝제, 에모리엔트 목적으로 배합되는 핵심 원료입니다. 한국 식약처(미규제) 및 유럽 CosIng(미규제) 등 6대 권역 법정 기준 하에 관리되며, 통상 0.05–5%(적정 pH 4–8) 범위에서 안정적으로 처방됩니다.

7대 갈래 국가별·용도별 공식 전성분 라벨 표기명 매트릭스

각국 1차 법원 고시 정본 · 기계번역·임의 음차 0건
7-Track Official Statutory Label Names for LECITHIN
국가·규제 트랙공식 고시 전성분 표기명원클릭 복사
① 한국 (MFDS 화장품 한글 표준명)레시틴
② 한국 구명칭 (개정 전 이력 · 301 리다이렉트)——
③ 유럽 (EU CosIng EC 1223/2009)LECITHIN
④ 미국 일반화장품 (US PCPC / MoCRA INCI)LECITHIN
⑤ 미국 OTC (FDA Active Ingredient Monograph)— (비-OTC 일반 화장품 원료)—
⑥ 중국 (NMPA IECIC 표준 중문명)卵磷脂
⑦ 일본 일반화장품 / 의약부외품 (JCIA / MHLW)LECITHIN (표준 INCI 기준 · 임의 가타카나 변환 배제)

Layer 1 — 글로벌 6대 권역 법정 배합 한도 및 규제 상태

Layer 1 Statutory Regulatory Limits Across 6 Regions for LECITHIN
권역규제 상태배합 한도제한 조건 및 1차 법원 출처
한국 (MFDS)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
유럽 (CosIng)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
미국 (FDA/CIR)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
중국 (NMPA)등재·허용GMPIECIC Entry #4456
일본 (MHLW)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
아세안 (ACD)미규제GMP공식 화장품 원료 목록 등재 (GMP 기준 사용)
⚠️ 참조용 안내 (법적 면책 공지): 이 사전의 성분명·규제 한도·배합 가이드는 연구·개발 참조용으로만 제공됩니다. 각국 고시 개정 시차나 데이터 오기·누락이 있을 수 있으므로, 실제 제품 처방·라벨 표기·인허가 전에는 반드시 관할 기관(식약처 등)의 최신 공식 고시 원문을 직접 확인하시기 바라며, 본 사전의 정보를 잘못 사용하여 발생하는 문제에 대해 운영 주체는 법적 책임을 지지 않습니다.
제형군별 사분위수(Min–Q1–Median–Q3–Max) 분포 그래프

Layer 3 제형군별 통상 배합 농도(%) 레인지 & Layer 1 법정 한도 대조

O/W · W/O 에멀전·크림n=10
Min 0.05% · Q1 0.1625% · Median 0.75% · Q3 1.5% · Max 5%
자외선차단·색조n=25
Min 0.3% · Q1 0.8% · Median 1% · Q3 1% · Max 1.5%
O/W · W/O 에멀전·크림 — 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝
공식 검증 원천: Global Starter Formulation Library Statistical Distribution (n=10, GRANT 9 · ELEMENTIS 1) (cir_safety) · GRANT 9 · ELEMENTIS 1
권장 중앙값: 0.75%

Layer 3 — 제형군별 통상 배합 농도(n≥5 사분위수) & 물리화학·상용성 가이드

Layer 3 Formulation Concentration Quartiles by Product Category for LECITHIN
제형군 분류Min – Q1 – Median – Q3 – Max (%)처방 역할 및 기전Source ID
제형군 B — 유화 로션 · 에멀전 · 크림 (O/W · W/O)0.05% · 0.1625% · 0.75% · 1.5% · 5%유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝Global Starter Formulation Library Statistical Distribution (n=10, GRANT 9 · ELEMENTIS 1)
제형군 D — 자외선차단제(선크림) · 색조 · 파운데이션0.3% · 0.8% · 1% · 1% · 1.5%선케어·색조 메이크업 분산 안정화 및 발림성 조절Global Starter Formulation Library Statistical Distribution (n=25, GRANT 25)
피부 투과 과학 시각화 (Bos & Meinardi 500 Dalton Rule)MW: Macro/Complex · LogP: N/A

각질층 장벽 투과 깊이 & 바이오 스피큘 경피전달(DDS) 시뮬레이션

각질층 (Stratum Corneum · 10~20 µm)500 Dalton 장벽 (고분자·친수성 성분 차단)생존 표피층 (Viable Epidermis · 50~100 µm)멜라닌세포 · 각질형성세포 타깃 (미백·장벽·턴오버)진피 유두층 (Papillary Dermis · 150~300 µm)섬유아세포 콜라겐 I/III · 엘라스틴 · PDRN 재생 타깃표피~상부 진피 확산 (<500 Da)
분자량(MW) & 친유성(LogP) 투과 판정
저분자 영역 (320 Da ≤ 500 Da) — 각질층 수동 확산 가능

단독 도포 시 각질층 세포간 지질(Brick & Mortar) 경로를 통해 확산됩니다. 500 Dalton 이상 친수성 분자는 각질층 표면에 주로 머물러 보습·보호막 역할을 수행합니다.

예상 도달 깊이
40–90 µm
권장 전달 시스템
Polyol Enhancer / Serum
계면화학 · pH · 열역학 공정 시각화

pH 안정성 스펙트럼(0~14) · 가열 한계 게이지 · HLB 콜로이드 상거동

Water or glycol phase soluble/dispersible
적정 처방 pH 안전 윈도우 (pH 0 ~ 14 스펙트럼)pH 4.0 – 8.0
0245.5791114

권장 구간 밖(pH < 4 또는 pH > 8)에서는 가수분해·점도 저하·이온 탈리 위험이 증가합니다.

공정 가열 한계 온도 (Max Process Temp)≤ 50°C
25°C45°C60°C75°C85°C100°C

최대 50°C 가열 공정에서 열적 안정성이 유지됩니다.

계면활성·유화 HLB 스펙트럼 (0 ~ 20) & 미셀/액정 배열 시뮬레이터
O/W 수중유형 미셀 에멀전 (수분 크림·로션)
HLB 11.5
W/O (3–6)Lamellar (8–10.5)O/W Emulsion (11–15)Solubilizer (15–19)O/W Droplet
생화학 신호전달 경로 (Biochemical Pathway Map)

세포·분자 타깃 작용 기전 플로우 다이어그램

1. 각질층·표피 작용→ 촉진·활성 (Activation)
각질층 세포간 지질 & 수분 결합 네트워크
→
경피수분손실(TEWL) 억제 및 피부결 개선
2. 염증 매개체 조절⊣ 억제·차단 (Inhibition)
외부 자극 유도 산화 스트레스(ROS) 및 사이토카인
⊣
피부 진정 및 항상성 유지
처방 온톨로지 네트워크 그래프

권장 시너지(🟢 실선) & 배합 금기·주의(🔴 점선) 인터랙티브 관계도

+ GLYCERIN+ CAPRYLIC/CAPRIC TR…+ TOCOPHEROL✕ 처방 내 극단적 pH 조건 및 고농도…LECITHIN
노드 인터랙션 가이드

🟢 초록색 시너지 원료 노드를 클릭하면 해당 원료 모노그래프로 즉시 이동하며, 🔴 붉은색 점선 노드를 클릭하면 화학적 상충(석출·변색·실활) 메커니즘을 표시합니다.

대표 상용명 참고 (상표법 제90조 제1항 제2호 설명적 표기)
LECITHIN

상용명 표기는 상표법 제90조 제1항 제2호에 의거하여 연구원에게 원료 등급·규격을 설명하기 위한 참고용이며, 각 상표의 권리는 해당 원료사에 귀속됩니다.

학술·독성·제형 종합 요약 (Tier 1~3 탄력 요약)

Tier 1 Synthesis

이 원료에 매칭된 PubMed 동료심사 논문 초록과 공인 독성 보고서만으로 작성된 학술 요약입니다.

■ [1. 화학적 정체성 및 규격 (Chemical Identity & Standard Nomenclature)] - 표준명: 레시틴 | INCI: LECITHIN | CAS No.: 8002-43-5 | EC No.: 232-307-2 - 기원 및 분류: PLANT | 주요 기능: 대전방지제, 피부컨디셔닝제, 에모리엔트, 유화제 - 물리화학 스펙: 분자식 복합 조성이거나 단일 화학식 미지정 | 분자량 고분자/복합물(Polymer/Complex) | 친수/친유 밸런스 특화 | 이온성: non-ionic | CosIng/MFDS 등재 - 7대 권역 공식 라벨 표기: KR [레시틴] · EU [LECITHIN] · US [LECITHIN] · CN [卵磷脂] · JP [-] · JP의약부외품 [-] ■ [2. 피부과학적 작용 기전 및 제형 내 역할 (Mechanism of Action & Function)] - 이 원료는 스테아릭애씨드, 팔미틱애씨드 및 올레익애씨드의 천연에 존재하는 다이글리세라이드 혼합물로 포스포릭애씨드의 콜린에스터에 결합되어 있으며 살아있는 동식물에서 발견된다. 물리화학적 분류상 기원(plant)에 기반하여 피부 장벽 및 제형 매트릭스 내에서 고유한 기능(대전방지제, 피부컨디셔닝제, 에모리엔트, 유화제)을 수행하며, 계면 안정화·보습·피부 컨디셔닝 또는 유효성분 전달에 기여합니다. ■ [3. 글로벌 6대 권역 법정 규제 및 안전성 한도 (Layer 1 & Layer 2 Regulatory Matrix)] - 6개국 요약: KR: NONE | EU: NONE | US: NONE | CN: ALLOWED | JP: NONE | ASEAN: NONE (중국 IECIC(2025) 등재번호 4456 (卵磷脂)) - 6대 주요 권역(KR·EU·US·CN·JP·ASEAN) 별도 배합금지/특수제한 고시 없음 (GMP 일반 안전 기준 내 배합 허용). - 공인 안전성·역사적 사용 농도(Layer 2): 제형 목적 및 GMP 안전성 평가 범위 내 적량(QS) 사용 ■ [4. 제형군별 통상 배합 가이드 (Layer 3-A Formulation Dosage Guide)] - [emulsion_cream] 권장 범위: 0.05 ~ 5.0% (중앙값 0.75%, 근거: Global Starter Formulation Library Statistical Distribution (n=10, GRANT 9 · ELEMENTIS 1)) — 유화 로션·크림 제형 구조 형성 및 피부 컨디셔닝 - [sun_color] 권장 범위: 0.3 ~ 1.5% (중앙값 1.0%, 근거: Global Starter Formulation Library Statistical Distribution (n=25, GRANT 25)) — 선케어·색조 메이크업 분산 안정화 및 발림성 조절 ■ [5. 연구원 공정 설계 · 안정성 · 배합 금기 (Layer 3-B Process & Compatibility)] - 투입 공정(Phase): Water Phase or Cool-down Phase (< 45°C) - 적정 pH 구간: pH 4.0 ~ 8.0 | 공정 내열 온도: 최대 50°C | 전해질(염) 내성: MEDIUM - 배합 주의/금기: 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장 - 시너지 추천 원료: GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL | 참고 상용 원료명: LECITHIN ■ [6. 학술 논문 및 공인 문헌 근거 (Peer-Reviewed Literature & Compendia)] - PMID 41987370 (2026, Skin Res Technol): Shake-Induced Temporary Ion-Pairing Between Lecithin and Glycolic Acid for Enhanced Exfoliation in a Novel Biphasic Seru - PMID 42013529 (2026, J Colloid Interface Sci): Unravelling the mechanisms behind the stabilization of oil foams using soybean lecithin - PMID 41913074 (2026, J Sci Food Agric): Recycling of hazelnut waste: Antidiabetic properties of soy lecithin nanoparticles and their in vitro anti-proliferative

근거 동료심사 학술 논문 (미국 NIH PubMed) (12)

Shake-Induced Temporary Ion-Pairing Between Lecithin and Glycolic Acid for Enhanced Exfoliation in a Novel Biphasic Serum: Comparative Ex Vivo and in Vivo Randomised Studies [PMID: 41987370 · 2026]
Kwon KC, Kim MJ · Skin Res Technol (2026)

Chemical exfoliation efficacy is significantly limited by pH-dependent permeability reduction above the pKa of glycolic acid (3.83), constraining consumer product development. To develop and evaluate a biphasic serum utilizing temporary lecithin-glycolate ion-pairing to enhance stratum corneum permeation while maintaining safety at pH 3.9. A biphasic formulation containing 10&#xa0;wt% (weight percent) glycolic acid and 0.1&#xa0;wt% lecithin was developed. Temporary ion-pairing was characterized by FT-IR spectroscopy. Ex vivo permeation and exfoliation were evaluated using porcine skin models. A 2-week double-blind, split-face clinical study (n = 37) assessed efficacy using instrumental probes (Visioscan, Corneofix, VISIA-CR, and ANTERA 3D) for exfoliation-related parameters and sensitive skin compatibility. FT-IR analysis confirmed lecithin-glycolate bonding via red-shifted C = O peaks, with spectral comparisons before and after shaking demonstrating the reversible nature of the change. The biphasic serum achieved 4.19-fold higher epidermal glycolic acid delivery compared to conventional formulations with minimal deep penetration. Clinical evaluation demonstrated superior exfoliation (45.52% improvement, p &lt; 0.001), enhanced skin brightness, texture, and hydration. Redness and transepidermal water loss, assessed for sensitive skin suitability, showed significant improvements. The biphasic system successfully overcomes pH-dependent limitations of glycolic acid through temporary ion-pairing, providing enhanced exfoliation efficacy with a superior safety profile for consumer applications.

Unravelling the mechanisms behind the stabilization of oil foams using soybean lecithin [PMID: 42013529 · 2026]
Argyri SM, Saint-Jalmes A, Ugarte-Pereyra C, Bordes R, Vincent-Bonnieu S, Le Coeur C, Binks BP, Schneck E, Fameau AL · J Colloid Interface Sci (2026)

Oil foams are emerging as a promising, versatile system in food, cosmetic and pharmaceutical applications. Existing solutions depend on the addition of particles or surfactant crystallization; however, these approaches often require complex processing steps, introduce solid residues that may affect texture, and rely on kinetically trapped interfacial structures that limit reversibility under ambient conditions. Here, we examine the foamability and stability of food-grade, soybean lecithin in oil of different surface tension. We found that edible oil foams can be formed at room temperature only in long-chain triglyceride oils. By combining microscopy, X-ray techniques, and interfacial rheology, we show that the stabilization arises from the formation of inverse lipid bilayers at the air-oil surface, leading to increased surface elastic modulus and dense thin-films that protect the gas bubbles. We also discovered that different self-assembled structures are formed in different oils. These findings uncover a molecular mechanism for non-aqueous foam stabilization under ambient conditions and establish design principles for surfactant-stabilized oil foams, without particle additives or crystallization.

Recycling of hazelnut waste: Antidiabetic properties of soy lecithin nanoparticles and their in vitro anti-proliferative effects in tumor cell lines [PMID: 41913074 · 2026]
Temiz MA, Okumus E · J Sci Food Agric (2026)

Hazelnuts and foods produced using hazelnuts are consumed with pleasure, but it is important to evaluate the waste generated during hazelnut processing and determine their usage methods. This study was conducted to determine the changes in bioactive components, bioaccessibility and antidiabetic activity of nanoparticles synthesized using soy lecithin from hazelnut wastes. The shell-derived nanoparticles had the highest zeta potential (-38.62&#x2009;mV), and the smallest particle size and polydispersity index values. The production efficiency of nanoparticles was in the range of 79.10-89.46%, and the loading capacity was in the range of 38.17-52.59%. The antioxidant properties and thermal stability of the shell nanoparticle were higher. The highest gallic acid, rutin, o-coumaric acid, quercetin and kaempferol were measured in shell nanoparticles. In the bioaccessibility results, gallic acid (69.47%), protocatechuic acid (61.28%), quercetin (61.50%) and kaempferol (52.07%) were at the highest values in the shell nanoparticle. Lipid peroxidation inhibition was highest in shell nanoparticles (8.41&#x2009;mg&#x2009;mL -1 ), while the lowest effect was measured in husk nanoparticles. The order of antidiabetic activity was shell nanoparticles &gt; skin nanoparticles &gt; husk nanoparticles. The investigation revealed that the nanoparticles exhibited significant anticancer activity in the MCF-7 breast cancer and HT-29 colon cancer cell lines. Principal component analysis showed that antioxidant properties are the key drivers of principal component one (PC1), while enzyme activities influence principal component two (PC2). The results obtained revealed the potential use of nanoparticles produced from hazelnut waste (especially shell) for therapeutic purposes and prevention of diseases associated with oxidative stress. &#xa9; 2026 The Author(s). Journal of the Science of Food and Agriculture published by John Wiley &amp; Sons Ltd on behalf of Society of Chemical Industry.

Retinol-Loaded Mannosylerythritol Lipid Nanoliposome for Enhanced Human Skin Penetration [PMID: 42246630 · 2026]
Park HW, Yoo DS, Jeong CJ, et al. · Skin Res Technol (2026)

Functional cosmetic materials with anti-aging properties, such as wrinkle reduction, often struggle to penetrate the skin's stratum corneum (skin barrier). Therefore, to exert anti-aging effects, these materials must pass through the skin barrier and reach fibroblasts in the dermal layer. In this study, deformable liposomes were developed for efficient transdermal delivery of retinol, a well-known anti-wrinkle agent. Five formulations (ML-1 to ML-5) were prepared using hydrogenated lecithin (HL) and mannosylerythritol lipid (MEL) as an edge activator with HL:MEL mass ratios of 10:0, 7:3, 5:5, 3:7, and 0:10. Their physicochemical properties, including particle size, zeta potential, polydispersity, encapsulation efficiency and deformability index were analyzed. For the optimal formulation, the liposome morphology was observed using cryo-TEM, and the retinol skin penetration ability of each liposome formulation was evaluated using a Franz diffusion cell. Their physicochemical properties were investigated, and ML-4 with an HL:MEL mass ratio of 3:7 was identified as the optimal formulation for transdermal delivery (particle size 89.3&#xb1;6.8&#xa0;nm, zeta potential -25.2&#xb1;1.1&#xa0;mV, polydispersity index 0.263&#xb1;0.012, encapsulation efficiency 86.3&#xb1;2.3%, and deformability index 5.76&#xb1;1.9). Cryo-TEM analysis confirmed the liposomal morphology of ML-4. The retinol skin penetration ability of each formulation was evaluated using the Franz diffusion cell, with the conventional liposome (ML-1) without MEL as the control. The ML-4 formulation achieved a total retinol penetration of 29.0%, a 10.6% increase compared to ML-1 (18.4%). In this study, the ML-4 deformable liposome formulation, using MEL as an edge activator, efficiently encapsulates retinol, a wrinkle improvement agent, and improves skin penetration without causing physical damage. These findings suggest that ML-4 can serve as an efficient transdermal delivery system for functional cosmetic materials.

Stratum corneum lipid remodeling as a proposed mechanism for liposomal penetration enhancement [PMID: 42242510 · 2026]
Andersen NS, Ruiz GCM, Sørensen JA, et al. · Eur J Pharm Biopharm (2026)

The stratum corneum (SC) is the principal barrier to topical and transdermal delivery, yet how lipid-based formulations interact with the SC lipid matrix remains incompletely resolved. Here, we compared conventional lecithin/cholesterol liposomes, hexosomes, ultradeformable liposomes, and a surfactant-only micelle control in ex vivo human skin after 4&#xa0;h Franz-cell exposure. Depth-resolved Laurdan generalized polarization (GP) imaging of cryosections was used to quantify formulation-induced changes in SC lipid organization, while DiD fluorescence and deuterated-lipid stimulated Raman scattering (SRS) provided orthogonal readouts of formulation-derived material within the tissue. Across formulations, GP decreased relative to matched controls, with the largest effects in the outer SC. Hexosomes produced larger outer-SC GP reductions than conventional liposomes (&#x394;GP &#x2248; 0.25-0.33 vs 0.14-0.18). In a separate donor-matched series, ultradeformable vesicles induced stronger SC remodeling than conventional liposomes, whereas Tween 20 micelles produced smaller effects. DiD and SRS signals were predominantly localized to the SC and decreased with depth, with SRS indicating a more surface-weighted distribution for rigid liposomes than for ultradeformable vesicles. Together, these findings identify formulation-dependent SC lipid remodeling, involving lipid redistribution and reduced local packing order, as a plausible mechanism by which lipid-based formulations may contribute to penetration enhancement reported in previous studies.

Impact of cationic, anionic, and amphiphilic emulsifiers on the physicochemical properties and applications of xanthan gum-shea butter bigels [PMID: 42190786 · 2026]
Jujjuri L, Elumalai S, K P V, et al. · Int J Biol Macromol (2026)

Bigels (BGs) have gained significant interest as versatile semisolid systems capable of immobilising both hydrophilic and lipophilic phases, making them suitable carriers for drug delivery. The current paper discusses the formulation of bigels (BGs) by combining xanthan gum (XG) based hydrogel (HG) with shea butter-hempseed oil-based oleogel (OG). The influence of emulsifier types, sodium dodecyl sulfate (SDS), soy lecithin (SL) and cetyltrimethylammonium bromide (CTAB), along with varying polymer concentration (1-5% w/w), on the physicochemical properties of the BGs was systematically investigated and characterized. The prepared bigels showed high oil binding capacity (&gt;95%), indicating good structural integrity. Microscopic analysis revealed that the BGs exhibited an oleogel (OG)-in-hydrogel (HG) dispersed system, corresponding to an oil-in-water (O/W) structure. Rheological studies revealed dominant elastic behaviour (G'&#xa0;&gt;&#xa0;G''), with CTAB-based formulations showing greater network strength. Fourier-transform infrared (FTIR) confirmed successful integration of hydrogel and oleogel phases without significant chemical interactions. Differential scanning calorimetry (DSC) analysis indicated improved thermal stability with increasing XG concentration, along with variations in crystallinity depending on emulsifier type. The in vitro drug release studies of Mupirocin (Mup) were best fitted by Korsmeyer-Peppas and Peppas-Sahlin models, suggesting Fickian diffusion as the principal release mechanism, with SL-based bigels showing comparatively higher drug release (~46%), Furthermore, the Mup-loaded BGs exhibited significant antimicrobial activity against Staphylococcus aureus, with inhibition zones of approximately 2.9&#xa0;cm, confirming their suitability for topical drug delivery applications.

A Kangfuxin-Loaded Lipid Gel for the Management of Radiation Dermatitis: Repair and Protection [PMID: 42173826 · 2026]
Wang T, Zhang W, Sun P, et al. · ACS Appl Mater Interfaces (2026)

Radiation therapy often causes oxidative stress and inflammation in normal tissues due to the generation of excessive radiation-induced reactive oxygen species (ROS). This can subsequently lead to radiation-induced skin injury (RISI), which manifests as tissue damage ranging from dermatitis to ulcers. One approach to addressing these challenges is to develop biocompatible functional materials that can facilitate repair and improve treatment tolerance by neutralizing ROS. In this study, a water-responsive lipid gel (LG) delivery system was constructed using Kangfuxin liquid (KFX, the ethanol extract of Periplaneta americana L.), soybean lecithin (SPC), and glycerol dioleate (GDO), based on KFX's broad-spectrum free radical scavenging ability, anti-inflammatory properties, and prorepair properties. Due to the molecular self-assembly properties of SPC and GDO, the KFX LG system can physically cross-link to form an in situ gel barrier upon contact with water. The barrier exhibits exceptional tissue adhesion, long-term slow-release properties, and good biocompatibility. The versatile KFX LG system has also been found to effectively remove various types of free radicals and reduce levels of proinflammatory factors. In a mouse model of radiation dermatitis, the radioprotective properties of the KFX lipid gel were demonstrated to be effective in alleviating radiation dermatitis. This study explored the radioprotective potential of KFX LG biomaterials in the context of radiation dermatitis, highlighting the application of radioprotectants as a promising RISI treatment strategy.

Comparison of Selected Pro-Health Biologically Active Chemical Compounds in Salviae herba from Selected Species [PMID: 42123793 · 2026]
Chwil M, Neugebauerová J, Matraszek-Gawron R, et al. · Molecules (2026)

Pharmaceutical, cosmetic, and food industries have contributed to the increasing interest in herbal phytochemicals. Salvia , a multifunctional culinary herb, meets phytotherapeutic requirements in the treatment of heartburn, excessive sweating, flatulence, and mouth, throat, and skin inflammatory conditions. Salviae folium is used in conductive education, i.e., a unique rehabilitation method for individuals with neurological and motor disorders designed to help in learning to perform activities independently. The comparative analysis of bioactive chemical compounds in S. officinalis , S. officinalis subsp. lavandulifolia , and S. sclarea herb showed that S. officinalis had the highest concentration of exogenous amino acids (53 mg&#xb7;g -1 DW), with a predominance of lecithin and phenylalanine, and endogenous amino acids were dominated by aspartic and glutamic acids. S. officinalis subsp. lavandulifolia was the richest source of omega-3, omega-6, and omega-9 fatty acids, followed by S. officinalis and S. sclarea . The vitamin C content was 4.9 ( S. sclarea )-14.4 mg&#xb7;100 g -1 DW ( S. officinalis ). Phenolic acids were dominated by rosmarinic acid ( S. officinalis &gt; S. officinalis sub. lavandulifolia &gt; S. sclarea ) and ferulic acid ( S. officinalis &gt; S. sclarea &gt; S. officinalis sub. lavandulifolia ). Salvia sclarea is a rich source of p -coumaric acid. Among non-phenolic organic acids, the highest content of quinic and malic acids was found in S. sclarea and S. officinalis , respectively. The level of o -dihydroxyphenols was 2140 ( S. officinalis )-2222 mg CAE&#xb7;100&#xb7;g -1 DW ( S. sclarea) . The flavonoid content was 610 ( S. officinalis subsp. lavandulifolia )-347 mg RU&#xb7;100 g -1 DW ( S. sclarea ). Flavonoids, flavonols, and flavanones were dominated by apigenin, kaempferol, and hesperidin, respectively. These metabolites may be potential components in phytotherapeutic products.

Assessment of skin permeation and anti-inflammatory efficacy of lornoxicam proniosomal topical gel formulations: a comparative study [PMID: 42084848 · 2026]
Alghaith AF, Mahrous GM, Shaaban DE, et al. · Pharm Dev Technol (2026)

Lornoxicam (LX) is a potent non-steroidal anti-inflammatory drug (NSAID) whose long-term oral administration is limited by gastrointestinal adverse effects. The present study aimed to develop and evaluate LX-loaded proniosomal topical gels as a strategy to enhance dermal permeation and anti-inflammatory efficacy, with direct comparison to a conventional LX gel. LX-loaded proniosomal Gels were formulated by combining lecithin, cholesterol, and a non-ionic surfactant. A conventional gel formulation was also prepared to compare its effectiveness with the proniosomal gel formulation. The vesicle size, Polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency, morphology, in&#xa0;vitro LX release, ex vivo , and finally, the anti-inflammatory efficacy of both formulations was thoroughly characterized. For the proniosomal variants, vesicle sizes were recorded at 373&#x202f;&#xb1;&#x202f;29&#x202f;nm for Span 60-based proniosomes (NS) and 230&#x202f;&#xb1;&#x202f;28&#x202f;nm for Tween 80-based proniosomes (NT), with corresponding PDI values of 0.23 and 0.31 and zeta potentials of -26&#x202f;mV and -28&#x202f;mV, respectively. Encapsulation efficiency exceeded 88% across both formulations. Notably, ex vivo evaluations demonstrated markedly improved skin permeation in the proniosomal gels. The Fluxes measured 51. &#xb5;g/cm 2 /h. for NS, 18.7 relative to the standard gel (12.4). These findings were corroborated by anti-inflammatory efficacy studies, which revealed statistically significant improvements with the proniosomal gel ( p &#x2009;&lt;&#x2009;0.05) compared to the standard formulation.

Photodynamic Versus Sonodynamic Therapy In Vitro: Antimicrobial Activity of Liposomal Rose Bengal [PMID: 42083964 · 2026]
Molina-Alejandre O, Villanueva-Martínez NA, Nava-Arzaluz MG, et al. · Curr Drug Deliv (2026)

To compare the antimicrobial effect of Photodynamic (PT) and Sonodynamic Therapy (ST) applying Rose Bengal (RB) loaded in liposomes, intended for the treatment of skin infections. Formulations with standard soy lecithin (TSRB) and water-soluble soy lecithin (TWRB) were prepared and characterized by: (i) FTIR-ATR and DSC, and measuring size, polydispersity index, and zeta potential; (ii) in vitro release and permeation tests, visualizing the distribution of RB in the skin by confocal laser microscopy; (iii) stability tests under different conditions; (iv) occlusion capacity tests; (v) determination of antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa; and (vi) cytotoxicity tests with HaCaT keratinocytes. Both formulations exhibited encapsulation rates &gt; 93% and particle sizes &lt; 100 nm. TWRB was more stable, delaying RB release (12.8 % at 8h) and facilitating its penetration into the skin. MRSA was inhibited with PT and ST. P. aeruginosa was inhibited with TWRB/ST. Viability was &gt;80% in HaCaT keratinocytes treated with TWRB/PT; however, acoustic cavitation caused significant cell detachment, precluding cytotoxicity assessment in ST assays. TWRB exhibited good technological and stability properties, capable of delaying RB release while enhancing its penetration into the skin. Although MRSA (Gram-positive) was inhibited, the most interesting results were obtained with P. aeruginosa (a Gram-negative bacterium, difficult to eradicate), as TWRB/ST completely inhibited it at a lower concentration than the RB solution. The results, particularly with P. aeruginosa, provide a basis for further studies using this system.

Pregabalin-loaded transferosomal gel for enhanced topical delivery in peripheral neuropathy: formulation, in vitro and ex vivo evaluation [PMID: 42083811 · 2026]
Sanjana A M, H M A · Drug Dev Ind Pharm (2026)

To formulate and evaluate a pregabalin-loaded transferosomal gel for transdermal delivery aimed at, improving skin penetration, sustaining drug release, and increasing patient compliance in the management of peripheral neuropathy. Oral pregabalin therapy often leads to systemic side effects and variable pharmacokinetics. A transferosome-based gel offers a novel approach to improve dermal penetration, prolong drug release, and reduce systemic exposure, potentially enhancing therapeutic outcomes in neuropathic pain. Pregabalin-loaded transferosomes were prepared using the thin-film hydration method with soya lecithin and Tween 80 in varying ratios. Formulations were evaluated for particle size, polydispersity index, zeta potential, entrapment efficiency, and morphology. The optimized formulation was incorporated into a gel and assessed for pH, drug content, in vitro drug release, ex vivo permeation through goat ear skin, irritancy using the hen's egg test on the chorioallantoic membrane, and stability for 90&#x2009;days. The vesicles displayed particle sizes of 378.9-1471&#x2009;nm, a PDI of 0.3-0.8, and a zeta potential from -17.2 to -31.6&#x2009;mV. Entrapment efficiency[ee] ranged from 40.35% to 89.2%. Scanning electron microscopy confirmed smooth, spherical vesicles. The transferosomal gel showed pH 5.2-6.1 and drug content of 93.4%-98.8%. In-vitro studies demonstrated sustained 24-hour release following the Korsmeyer-Peppas model. Ex-vivo permeation showed 92.2% permeation, a flux of 467.18&#x2009;&#xb5;g/cm 2 /h, and a lag time of 0.99&#x2009;h. The gel was nonirritant and stable for 90&#x2009;days. The developed transferosomal gel exhibited sustained release, efficient permeation, and good stability, indicating strong potential as a transdermal system for peripheral neuropathy management.

Cationic Corona-Engineered Polymer-Lipid Hybrid Nanoparticles for Enhanced Dermal Penetration and Cellular Bioavailability [PMID: 41937363 · 2026]
Seo Y, Yang J, Song M, et al. · Langmuir (2026)

Cationic polymer-lipid hybrid nanoparticles were engineered to overcome cytotoxicity limitations of conventional surfactants while achieving enhanced skin penetration and controlled drug release. Poly(2-ethyl-2-oxazoline)- block -poly(&#x3b5;-caprolactone) (POx- b -PCL) copolymers were synthesized via ring-opening polymerization and coassembled with lecithin through nanoprecipitation, yielding spherical nanoparticles (&#x223c;120 nm). Differential scanning calorimetry and NMR relaxometry confirmed that POx- b -PCL incorporation progressively increased the crystallinity and rigidity of the nanoparticle core, achieving 2-fold reduction in Higuchi release rate constants for sustained curcumin delivery. Biolayer interferometry demonstrated 10-fold enhanced binding affinity toward negatively charged albumin through multivalent electrostatic interactions, correlating with substantially improved cellular internalization in HaCaT keratinocytes. Confocal microscopy of ex vivo porcine skin revealed 70% increased transdermal penetration depth, with maximum fluorescence at 30-40 &#x3bc;m beneath the stratum corneum. These biocompatible nanocarriers synergistically integrate controlled release kinetics with cationic surface chemistry, presenting a promising platform for transdermal drug delivery and topical therapeutic applications.

자주 묻는 질문 (AEO 스니펫 최적화 FAQ)

Q1. 레시틴 (LECITHIN)의 국가별 공식 전성분 표기명은 어떻게 다른가요?
한국 식약처 표준명은 '레시틴', 미국 PCPC 및 유럽 CosIng INCI 표기는 'LECITHIN', 중국 NMPA IECIC 표준명은 '卵磷脂', 일본 화장품 표시명칭은 'LECITHIN'입니다.
Q2. 레시틴의 글로벌 6대 권역 법정 배합 한도(Layer 1)는 무엇인가요?
한국(KR: none), 유럽(EU: none), 미국(US: none), 중국(CN: allowed), 일본(JP: none), 아세안(ASEAN: none) 고시 기준을 준수하여 처방해야 합니다.
Q3. 제형 설계 시 레시틴의 통상 배합 농도(Layer 3)와 적정 pH는 얼마인가요?
대표 제형군(emulsion_cream) 기준 통상 0.05~5%(권장 중앙값 0.75%) 범위로 투입하며, 적정 pH는 4~8입니다.
Q4. 레시틴 배합 시 주의해야 할 상용성 금기(Incompatibilities)와 시너지 성분은 무엇인가요?
주요 권장 시너지 조합은 GLYCERIN, CAPRYLIC/CAPRIC TRIGLYCERIDE, TOCOPHEROL이며, 배합 주의사항은 처방 내 극단적 pH 조건 및 고농도 전해질과의 상용성 사전 확인 권장입니다.